Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy.
Publication
, Journal Article
Becker, RC
Published in: J Thromb Thrombolysis
October 2004
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
ISSN
0929-5305
Publication Date
October 2004
Volume
18
Issue
2
Start / End Page
153 / 155
Location
Netherlands
Related Subject Headings
- Thrombosis
- Receptors, Proteinase-Activated
- Humans
- Factor Xa
- Drug Therapy, Combination
- Drug Delivery Systems
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2004). Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy. J Thromb Thrombolysis, 18(2), 153–155. https://doi.org/10.1007/s11239-004-0212-x
Becker, Richard C. “Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy.” J Thromb Thrombolysis 18, no. 2 (October 2004): 153–55. https://doi.org/10.1007/s11239-004-0212-x.
Becker RC. Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy. J Thromb Thrombolysis. 2004 Oct;18(2):153–5.
Becker, Richard C. “Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy.” J Thromb Thrombolysis, vol. 18, no. 2, Oct. 2004, pp. 153–55. Pubmed, doi:10.1007/s11239-004-0212-x.
Becker RC. Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy. J Thromb Thrombolysis. 2004 Oct;18(2):153–155.
Published In
J Thromb Thrombolysis
DOI
ISSN
0929-5305
Publication Date
October 2004
Volume
18
Issue
2
Start / End Page
153 / 155
Location
Netherlands
Related Subject Headings
- Thrombosis
- Receptors, Proteinase-Activated
- Humans
- Factor Xa
- Drug Therapy, Combination
- Drug Delivery Systems
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences